The effects of aminoguanidine on renal changes in a baboon model of Type 1 diabetes

References

Page 1

	Year	Citations
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus New England Journal of Medicine	1993	24.5K
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. Richard Bucala, Kevin J. Tracey, Anthony Cerami Journal of Clinical Investigation Defective Endothelium-dependent VasodilatationNitric OxideGlycobiologyExperimental DiabetesOxidative Stress	1991	1.2K
Advanced Glycosylation End Products in Patients with Diabetic Nephropathy Zenji Makita, Steven Radoff, Elliot J. Rayfield, New England Journal of Medicine	1991	921
Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Helen Vlassara, Richard Bucala, Liliane J. Striker PubMed Metabolic SyndromeClinical ImplicationsPathogenic EffectsBiochemistryMedicine	1994	853
Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial The Diabetes Control and Complications Research Group Kidney International GlomerulonephritisIntensive TherapyComplications TrialRenal FunctionDiabetes Management	1995	693
Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Hans‐Peter Hammes, S. Martin, K. Federlin, Proceedings of the National Academy of Sciences Diabetic RetinopathyOcular DiseaseOphthalmologyExperimental OphthalmologyMedicine	1991	527
Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. Belay Tesfamariam, Michael L. Brown, Ran Cohen Journal of Clinical Investigation H. RelaxationsCardiovascular FunctionAtherosclerosisCell SignalingEnergy Homeostasis	1991	424
Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat T. Soulis-Liparota, M. E. Cooper, D. Papazoglou, Diabetes Mesangial ExpansionDevelopmental BiologyTissue FluorescenceMedicinePhysiology	1991	399
Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Helen Vlassara, H Fuh, Zenji Makita, Proceedings of the National Academy of Sciences AgingGlycosylation End ProductsGlycobiologyVascular PermeabilityMetabolic Syndrome	1992	382
Determination of membrane thickness distribution from orthogonal intercepts Eva B. Vedel Jensen, H. J. G. Gundersen, Ruth Østerby Journal of Microscopy	1979	356

Page 1